PLOSopen access

Leveraging current capacity to address the high prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs

Nkgomeleng A. Lekodeba et al.

PLOS · Papers · License: CC-BY

antibiotics, hiv clinical manifestations, hiv diagnosis and management, virus testing, hiv epidemiology, antibiotics

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Leveraging current capacity to address the high prevalence of <i>Chlamydia trachomatis</i>, <i>Neisseria gonorrhoeae</i>, and <i>Trichomonas vaginalis</i> in South Africa: Modelling potential costs and benefits of near point-of-care GeneXpert testing for STIs